1. A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices. (1st October 2018) Authors: Kechichian, E.; Ingen‐Housz‐Oro, S.; Sbidian, E.; Hemery, F.; Bernier, C.; Fite, C.; Delaunay, J.; Staumont‐Sallé, D.; Toukal, F.; Dupin, N.; Abasq, C.; Samimi, M.; Picard, C.; Hebert, V.; Prost, C.; Monfort, J.‐B.; Milpied, B.; Wolkenstein, P.; Chosidow, O. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Austenite formation in a ferrite/martensite cold-rolled microstructure during annealing of advanced high-strength steels. Issue 1 (14th February 2014) Authors: Philippot, C.; Drillet, J.; Maugis, P.; Hebert, V.; Dumont, M. Journal: Metallurgical research & technology Issue: Volume 111:Issue 1(2014) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Austenite formation in a ferrite/martensite cold-rolled microstructure during annealing of advanced high-strength steels. Issue 1 (4th April 2014) Authors: Philippot, C.; Drillet, J.; Maugis, P.; Hebert, V.; Dumont, M. Journal: Metallurgical research & technology Issue: Volume 111:Issue 1(2014) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Austenite formation in a ferrite/martensite cold-rolled microstructure during annealing of advanced high-strength steels. Issue 1 (4th April 2014) Authors: Philippot, C.; Drillet, J.; Maugis, P.; Hebert, V.; Dumont, M. Journal: Metallurgical research & technology Issue: Volume 111:Issue 1(2014) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid*. (1st June 2021) Authors: Masmoudi, W.; Vaillant, M.; Vassileva, S.; Patsatsi, A.; Quereux, G.; Moltrasio, C.; Abasq, C.; Prost‐Squarcioni, C.; Kottler, D.; Kiritsi, D.; Litrowski, N.; Plantin, P.; Friedrichsen, L.; Zebrowska, A.; Duvert‐Lehembre, S.; Hofmann, S.; Ferranti, V.; Jouen, F.; Joly, P.; Hebert, V. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid. (1st June 2021) Authors: Masmoudi, W.; Vaillant, M.; Vassileva, S.; Patsatsi, A.; Quereux, G.; Moltrasio, C.; Abasq, C.; Prost‐Squarcioni, C.; Kottler, D.; Kiritsi, D.; Litrowski, N.; Plantin, P.; Friedrichsen, L.; Zebrowska, A.; Duvert‐Lehembre, S.; Hofmann, S.; Ferranti, V.; Jouen, F.; Joly, P.; Hebert, V. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid. (29th November 2020) Authors: Masmoudi, W.; Vaillant, M.; Vassileva, S.; Patsatsi, A.; Quereux, G.; Moltrasio, C.; Abasq, C.; Prost‐Squarcioni, C.; Kottler, D.; Kiritsi, D.; Litrowski, N.; Plantin, P.; Friedrichsen, L.; Zebrowska, A.; Duvert‐Lehembre, S.; Hofmann, S.; Ferranti, V.; Jouen, F.; Joly, P.; Hebert, V. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (1st May 2020) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (28th November 2019) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗